Melanoma Treatment Guidelines 2021 Flashcards
Optimal biopsy for suspicious pigmented lesion
complete excision with 2 mm margin and deep into upper cutis
Punch biopsy is associated with
high rate of false neg
Saucerization my be performed with
flat lesions
MIS - Stage 0 - management
Primary care
Wide local excision 5-10 mm
Does not need sentinel node bx
Invasive melanoma, Breslow < 1 mm, no ulceration, no mitoses
Wide local excision, 10 mm
No SLNB
SLNB is necessary if …
Breslow > 0.1 mm
or Breslow > 0.8 with ulceration or mitoses
Or Bres
All positive SLNB are considered for …
Adjuvant Rx
Stage 1 and 2
Invasive melanoma with negative LNB
Stage 3 and 4
Invasive melanoma with + SLNB +/- distant mets
Stage 0 5 year survival
> 98%
Stage 1 (A/B), classification
T1a: < 0.8 mm and nonulcerated
T1b:>= 0.8 mm or < 0.8 with ulceration
T2a:> 1-2 mm without ulceration
Stage 1 (A/B), 5 year survival
97-92%
Stage II (A/B/C), classification
T2b:1-2 mm with ulceration T3a:2-4 mm without ulceration T3b:2-4 mm with ulceration T4a:>4 mm without ulceration T4b:>4 mm with ulceration
Stage II (A/B/C), 5 year survival
81-53%
Stage III (A/B/C/D), classification
N1a: 1 clinically occult (in snl bx)
N1b: 1 clinically detected
N1C: in transit, satellite, and or microsagellite mets
N2a: 2-3 clinically occult
N2b: 2-3, at least 1 clinically detected
N2c: 1 clinically occult or detected with in transit satellite and or microsatellite mets
N3a: 4 or more clinically occult
N3b: 4 or more, at least 1 clinically detected, or presence of matted nodes
N3c: 2 or more clinically occult or detected with in transit satellite and or microsatellite mets